Search Contract Opportunities

Preparation and Distribution of Research Drug Products   4

ID: 75N95024R00003 • Type: Solicitation • Match:  85%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

The NIDA Drug Supply Program plays a major role in promoting drug abuse and drug addiction research by providing to the drug abuse research community with a wide variety of authentic controlled and uncontrolled drug compounds, some of their dosage forms, and marijuana and nicotine research cigarettes for research. Through this contract NIDA plans to continue to acquire drug compounds, drug dosage forms for the NIDA drug supply inventory, to have capability to import drug compounds from international sources, to develop and prepare drug dosage forms, to have capability to manufacture marijuana and nicotine research cigarettes, to frequently analyze them for purity, and to store and distribute them for research upon NIDA authorization according to DEA regulations. Such dosage forms of controlled and uncontrolled drug compounds include morphine, methadone and naltrexone pellets of various strengths, their placebo counterparts, and various cannabinoid preparations (delta-8- and delta-9- tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene) and other compounds of interest to the drug abuse research community.

Upon issuance of Task Orders, the Contractor shall acquire, analyze, store, and ship bulk drugs, other chemical compounds, and drug dosage forms to aid NIDA in promoting drug abuse and drug addiction research.

Background
The National Institute on Drug Abuse (NIDA) is issuing this Request for Proposal (RFP) No. 75N95024R00003 titled 'Preparation and Distribution of Research Drug Products' to support drug abuse and addiction research.

The contract aims to provide a variety of authentic controlled and uncontrolled drug compounds, dosage forms, and research cigarettes to the drug abuse research community. This initiative is crucial for advancing research in drug addiction and abuse by ensuring access to necessary substances under strict regulatory compliance.

Work Details
The Contractor shall perform the following tasks: acquire, analyze, store, and ship bulk drugs and chemical compounds; develop and prepare drug dosage forms; manufacture marijuana and nicotine research cigarettes; frequently analyze these substances for purity; and ensure compliance with DEA regulations.

Specific dosage forms include morphine, methadone, naltrexone pellets of various strengths, placebo counterparts, and various cannabinoid preparations. The Contractor will also be responsible for reporting requirements including monthly progress reports, semi-annual reports, annual reports, and a final report summarizing the work conducted during the contract period.

Period of Performance
The anticipated period of performance for this contract is five years from the date of award.

Place of Performance
The work will primarily be performed at the Contractor's facilities but may involve shipping to various locations as required by NIDA.
Show All

Overview

Agency
National Institute on Drug Abuse (NIDA) [HHS - NIH]
Response Deadline
Nov. 15, 2024, 1:00 p.m. EST Past Due
Posted
Oct. 1, 2024, 2:06 p.m. EDT (updated: Oct. 28, 2024, 1:50 p.m. EDT)
Set Aside
None
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN11 - Health R&D Services; Health Care Services; Basic Research
Place of Performance
United States
Source
Open
Current SBA Size Standard
1000 Employees
Pricing
Multiple Types Common
Est. Level of Competition
High
On 10/1/24 National Institute on Drug Abuse issued Solicitation 75N95024R00003 for Preparation and Distribution of Research Drug Products due 11/15/24. The opportunity was issued full & open with NAICS 541715 and PSC AN11.
Primary Contact
Name
Scott Duernberger   Profile
Email
scott.duernberger@nih.gov
Phone
(301) 594-0670

Secondary Contact

Name
Josh Lazarus   Profile
Email
josh.lazarus@nih.gov
Phone
(301) 827-6923

Documents

Posted documents for Solicitation 75N95024R00003

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation 75N95024R00003

Award Notifications

Agency published notification of awards for Solicitation 75N95024R00003

IDV Awards

Indefinite delivery vehicles awarded through Solicitation 75N95024R00003

Incumbent or Similar Awards

Contracts Similar to Solicitation 75N95024R00003

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 75N95024R00003

Similar Active Opportunities

Open contract opportunities similar to Solicitation 75N95024R00003

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > NATIONAL INSTITUTES OF HEALTH > NATIONAL INSTITUTES OF HEALTH NIDA
FPDS Organization Code
7529-75N950
Source Organization Code
100189048
Last Updated
Nov. 15, 2024
Last Updated By
scott.duernberger@nih.gov
Archive Date
Nov. 15, 2024